Retraction of “Ravoxertinib Improves Long-Term Neurologic Deficits after Experimental Subarachnoid Hemorrhage through Early Inhibition of Erk1/2”
oleh: Ming-feng Yang, Sheng-yao Sun, Hai-guang Lv, Wei-qi Wang, Han-xia Li, Jing-yi Sun, Zong-yong Zhang
| Format: | Article |
|---|---|
| Diterbitkan: | American Chemical Society 2024-06-01 |
Deskripsi
No description available for this item.